The ECP/Eo count ratio in children with asthma

Journal of Asthma

Volumn 41, Issue 5, 2004, Pages 539-546

  Stelmach, Iwona ^a   Majak, Pawel ^a   Grzelewski, Tomasz ^a   Jerzynska, Joanna ^a   Jurałowicz, Dorota ^a   Stelmach, Wlodzimierz ^b   Borzecka Podsiadlowicz, Malgorzata ^a   Korzeniewska, Aleksandra ^a   Kuna, Piotr ^c  

^a M Curie Hospital   (Poland)

^b Regional Health Authority   (Poland)

^c MEDICAL UNIVERSITY OF LODZ   (Poland)

Author keywords

Asthma severity; Bronchial hyperreactivity; ECP Eo ratio

Indexed keywords

BETA 2 ADRENERGIC RECEPTOR STIMULATING AGENT; EOSINOPHIL CATIONIC PROTEIN; INTERCELLULAR ADHESION MOLECULE 1; INTERLEUKIN 2 RECEPTOR; SALBUTAMOL;

ADOLESCENT; ARTICLE; ASTHMA; BRONCHUS HYPERREACTIVITY; CHILD; DISEASE SEVERITY; EOSINOPHIL; FEMALE; FORCED EXPIRATORY VOLUME; HUMAN; LOGISTIC REGRESSION ANALYSIS; MAJOR CLINICAL STUDY; MALE; PROVOCATION TEST; SPIROMETRY;

ADOLESCENT; ASTHMA; BLOOD PROTEINS; CHILD; EOSINOPHIL GRANULE PROTEINS; EOSINOPHILS; FEMALE; HUMANS; LEUKOCYTE COUNT; MALE; RIBONUCLEASES; SEVERITY OF ILLNESS INDEX;

EID: 4444336366     PISSN: 02770903     EISSN: None     Source Type: Journal    
DOI: 10.1081/JAS-120037654     Document Type: Article

References (34)

1. Bousquet J, Courigan CJ, Venge P. Peripheral blood markers: evaluation and inflammation in asthma. Eur Respir J 1998; 26:42-48.
2. Grutters JC, Brinkman L, Aslander MM, van den Bosch JM, Koenderman L, Lammers JW. Asthma therapy modulates priming-associated blood eosinophil responsiveness in allergic asthmatics. Eur Respir J 1999; 14:915-922.
3. Crimi E, Spanevello A, Neri M, Ind PW, Rossi GA, Brusasco V. Dissociation between airway inflammation and airway hyperresponsiveness in allergic asthma. Am J Respir Crit Care Med 1998; 157:4-9.
4. Daher S, Santos LM, Sole D, De Lima MG, Naspitz CK, Musatti CC. Interleukin 4 and soluble CD23 serum levels in asthmatic atopic children. J Investig Allergol Clin Immunol 1995; 5:251-254.
5. Koller DY, Herouy Y, Gotz M, Hagel E, Urbanek R, Eichler I. Clinical value of monitoring eosinophil activity in asthma. Arch Dis Child 1995; 73:413-417.
6. Pizzichini E, Pizzichini MM, Efthimiadis A, Dolovich J, Hargreave FE. Measuring airway inflammation in asthma: eosinophils and eosinophilic cationic protein in induced sputum compared with peripheral blood. J Allergy Clin Immunol. 1997; 99:539-544.
7. Wardlaw AJ, Brightling CE, Green R, Woltmann G, Bradding P, Pavord ID. New insights into the relationship between airway inflammation and asthma. Clin Sci (Lond) 2002; 103:201-211.
8. Motojima S, Ogata H, Tateishi K, Fukuda T, Makino S, Koseki T, Adachi T, Kihara N. Measurement of serum and sputum eosinophil cationic protein concentration in asthma. Arerugi 1995; 44:1272-1281.
9. Zimmerman B, Lanner A, Enanober I. Total blood eosinophils, serum eosinophil cationic protein and eosinophil protein X in childhood asthma: relation to disease status and therapy. Clin Exp Allergy 1993; 23:564-570.
10. Gruber W, Eber E, Pfleger A, Modl M, Meister I, Weinhandl E, Zach MS. Serum eosinophil cationic protein and bronchial responsiveness in pediatrics and adolescent asthma patients. Chest 1999; 116:301-305.
11. Fuijtaka M, Kawaguchi H, Kato Y, Sakura N, Ueda K, Abe Y. Significance of the eosinophil cationic protein/eosinophil count ratio in asthmatic patients: its relationship to disease severity. Ann Allergy Asthma Immunol 2001; 86:323-329.
12. Imai C, Yamazaki H, Tanaka Y, Matsunaga M, Numata O, Torigoe K. Ratio of eosinophil cationic protein count as a new marker in children with acute asthma. Pediatr Int 1999; 41:142-146.
13. Koh YY, Kang H, Kim CK. Ratio of serum eosinophil cationic protein/blood eosinophil counts in children with asthma: comparison between acute exacerbation and clinical remission. Allergy Asthma Proc. 2003; 24:269-274.
14. Lai CK, Chan CH, Leung JC, Lai KN. Serum concentration of soluble interleukin 2 receptors in asthma. Correlation with disease activity. Chest 1993; 103:782-786.
15. Tsai LC, Tang RB, Hung MW, Chen HM, Tsai SJ. Expression of serum II-2, II-2R, and CD8 levels during hyposensitization in house dust-sensitive asthmatics. J Asthma 1990; 27:307-313.
16. El Sawy IH, Badr-El-Din OM, El-Azzouni OE, Motawae HA. Soluble intercelluar adhesion molecule-1 in sera of children with bronchial asthma exacerbation. Arch Allergy Immunol 1999; 119:126-132.
17. Shiota Y, Wilson JG, Marukawa M, Ono T, Kaji M. Soluble intercellular adhesion molecule 1 (ICAM-1) antigen in sera of bronchial asthmatics. Chest 1996; 109:94-99.
18. Highlights of the Expert Panel Report 2. Guidelines for the Diagnosis and Management of Asthma, NIH Publication No. 97-4051A; May 1997.
19. Santanello NC, Barber BL, Reiss TF, Friedman BS, Juniper EF, Zhang J. Measurement characteristics of two asthma symptom diary scales for use in clinical trials. Eur Respir J 1997; 10:646-651.
20. Cockcroft DW, Murdock KY, Mink JT. Determination of Histamine PC20. Chest 1983; 54:505-506.
21. Wever AM, Wever-Hess J, Hensgens HE, Hermans J. Serum eosinophil cationic protein (ECP) in chronic asthma. Relationship to spirometry, flow-volume curves, PC20, and exacerbations. Respir Med. 1994; 88:613-621.
22. Vatrella A, Ponticello A, Parella R, Romano L, Zofra S, DiLeva A, Bariffi F. Serum eosinophil cationic protein (ECP) as a marker of disease activity and treatment efficacy in seasonal asthma. Allergy 1996; 51:547-555.
23. Fergusson AC, Vaughan R, Brown H, Curtis C. Evaluation of serum eosinophilic cationic protein as a marker of disease activity in chronic asthma. J Allergy Clin Immunol 1995; 95:23-28.
24. Ronchi MC, Piragino C, Rosi E, Stendardi L, Tanini A, Galli G, Duranti R, Scano G. Do sputum eosinophil and ECP relate to severity of asthma? Eur Respir J 1997; 10:1809-1813.
25. Prehn A, Seger RA, Faber J, Torresani T, Molinari L, Gerber A, Sennhauser FH. The relationship of serum-eosinophil cationic protein and eosinophil count to disease activity in children with bronchial asthma. Pediatr Allergy Immunol 1998; 9:197-203.
26. Vanto T, Koskinen P. Serum eosinophil cationic protein in the evaluation of asthma severity in children. Allergy 1998; 53:415-419.
27. Ferdousi HA, Dreborg S. Asthma, bronchial hypereactivity and mediator release in children with birch pollinosis. ECP and EPX levels are not related to bronchial hyperreactivity. Clin Exp Allergy 1996; 27:530-539.
28. Niimi A, Amitani R, Suzuki K, Tanaka E, Murayama T, Kuze F. Serum eosinophil cationic protein as a marker of eosinophilic inflammation in asthma. Clin Exp Allergy 1998; 28:233-240.
29. Pronk-Admiraal CJ, Haitjema T, Horikx P, Bartels PC. Surplus value of eosinophil count and ECP to diagnose and monitor asthmatic patients. Neth J Med. 2001; 58:9-17.
30. Obase Y, Shimoda T, Mitsuta K, Matsuo N, Matsuse H, Kohno S. Sensitivity to the house dust mite and airway hyperresponsiveness in a young adult population. Ann Allergy Asthma Immunol 1999; 83:305-310.
31. Shi HZ, Sun JJ, Pan HL, Lu JQ, Zhang JL, Jiang JD. Alternations of T-lymphocyte subsets, soluble IL-2 receptor and IgE in peripheral blood of children with acute asthma attacks. J Allergy Clin Immunol 1999; 103:388-392.
32. Cengizlier R, Demirpolat E, Tulek N, et al. Circulating ICAM-1 levels in bronchial asthma and the effect of inhaled corticosteroids. Ann Allergy Asthma Immunol 2000; 84:539-541.
33. Pronk-Admiraal CJ, Bartels PCM, Mulder K. Eosinophil cationic protein in serum from non-atopic and asymptomatic atopic individuals after standardized blood clotting at 37 C. Ann Clin Biochem 1999; 36:353-358.
34. Sont J, Willems LN, Bel EH, van Krieken JH, Vandenbroucke JP, Sterk PJ. Clinical control and histopatologic outcome of asthma when using airway hyperresponsiveness as an additional guide to long-term treatment. Am J Respir Crit Care Med. 1999; 159:1043-1051.